David Hung
At a glance: David Hung is Director at NovoCure (NVCR). Their latest SEC Form 4, filed Jun 3, 2026, reported a sale of $46K. On file: 0 purchase lines ($0) and 1 sale line ($46K).
Disclosed holdings: about $218K of NVCR stock: 20,465 shares reported on their latest Form 4 (filed Jun 3, 2026), valued at the Nov 19, 2026 close of $10.65. This counts only NVCR shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at NovoCure Ltd (NVCR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
David Hung's InsiderPrint
3 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
Reading this print: Mostly buys, trading about 3 times a year, typically $332K a trade; often buys after the stock has fallen 15% or more.
- Bump outward: a purchase (2)
- Dent inward: a sale (1)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Framework Ventures Management LLC10% Owner · BETR · 99% match
- Dominic Benjamin James WellsCEO, Chair · ONFO · 97% match
- Aaron CowenDirector · BNTC · 97% matchTheir buys since 2022: 2 of 4 beat the S&P 500
- Jacob Steven LeachCOO, President · DXCM · 97% match
- Jeff LeblancCFO · GRML · 97% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
Follow David Hung
Get one email when David Hung files a new purchase or sale. Free.
At most one email a day about David Hung, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.